CrestPoint Capital Management’s Eli Lilly LLY Stock Holding History

CrestPoint Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.08M	Sell	12,800 -2,700	-17%	-$230K	0.6%	57
2017 Q3	$1.33M	Sell	15,500 -700	-4%	-$57.4K	0.59%	55
2017 Q2	$1.33M	Buy	16,200 +4,000	+33%	+$326K	0.63%	55
2017 Q1	$1.03M	Buy	12,200 +9,300	+321%	+$745K	0.49%	68
2016 Q4	$213K	Hold	2,900	–	–	0.11%	210
2016 Q3	$233K	Buy	2,900 +20	+0.7%	+$1.6K	0.12%	202
2016 Q2	$227K	Hold	2,880	–	–	0.12%	192
2016 Q1	$207K	Hold	2,880	–	–	0.11%	201
2015 Q4	$243K	Hold	2,880	–	–	0.14%	165
2015 Q3	$241K	Hold	2,880	–	–	0.14%	170
2015 Q2	$240K	Hold	2,880	–	–	0.13%	202
2015 Q1	$209K	Buy	+2,880	New	+$205K	0.11%	213
2014 Q3	–	Sell	-4,480	Closed	-$279K	–	214
2014 Q2	$279K	Sell	4,480 -200	-4%	-$11.9K	0.16%	176
2014 Q1	$275K	Sell	4,680 -8,400	-64%	-$469K	0.17%	177
2013 Q4	$667K	Buy	+13,080	New	+$655K	0.44%	86

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CrestPoint Capital Management's LLY Position: Q4 2017 in Review

CrestPoint Capital Management reduced its Eli Lilly (LLY) stake by 17% in Q4 2017, selling an estimated $230K and leaving 12,800 shares worth $1.08M. The position accounts for 0.6% of the portfolio, ranked #57.

CrestPoint Capital Management first reported a position in LLY in Q4 2013 and has held it in 15 quarters since. The position peaked at $1.33M in Q2 2017. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

CrestPoint Capital Management held 12,800 shares of Eli Lilly worth $1.08M as of Q4 2017.
CrestPoint Capital Management sold 2,700 Eli Lilly shares in Q4 2017, an estimated $230K.
Eli Lilly made up 0.6% of CrestPoint Capital Management's portfolio in Q4 2017, its #57 holding.
CrestPoint Capital Management first reported a position in Eli Lilly in Q4 2013 and has held it in 15 quarters since.
CrestPoint Capital Management's Eli Lilly position peaked at $1.33M in Q2 2017.
1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.